Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy

Kendra J. Grubb, Nikoloz Shekiladze, Julianne Spencer, Emily Perdoncin, Gilbert H.L. Tang, Joe Xie, John Lisko, Jorge Zhingre Sanchez, Lindsay M. Lucas, Janarthanan Sathananthan, Toby Rogers, G. Michael Deeb, Shinichi Fukuhara, Philipp Blanke, Jonathon A. Leipsic, John K. Forrest, Michael J. Reardon, Patrick Gleason

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Background: Transcatheter aortic valve implantation in an existing transcatheter valve (redo-TAVI) pins the index valve leaflets in the open position (neoskirt), which can cause coronary flow compromise and limit access. Whether anatomy may preclude redo-TAVI in self-expanding Evolut valves is unknown. Aims: We aimed to evaluate the anatomical feasibility of redo-TAVI by simulating implantation of a balloon-expandable SAPIEN 3 (S3) within an Evolut or an Evolut within an Evolut. Methods: A total of 204 post-TAVI computed tomography (CT) scans from the Evolut Low Risk CT substudy were analysed. Five redo-TAVI positions were evaluated: S3-in-Evolut inflow-to-inflow, S3 outflow at Evolut nodes 4, 5, and 6, and Evolut-in-Evolut inflow-to-inflow. Univariable modelling identified pre-TAVI clinical characteristics, CT anatomical parameters, and procedural variables associated with coronary flow compromise using the neoskirt height and post-TAVI aortic root dimensions. Results: The risk of coronary flow compromise was lowest when the S3 outflow was at Evolut node 4 (20%) and highest when at Evolut node 6 (75%). The highest likelihood of preserving coronary accessibility occurred with the S3 outflow at Evolut node 4. Female sex and higher body mass index were associated with a higher risk of coronary flow compromise, as were a smaller annulus diameter, lower sinus of Valsalva height and width, shorter coronary height, smaller sinotubular junction diameter, and shallower Evolut implant depth. Conclusions: The feasibility of redo-TAVI after Evolut failure is multifactorial and relates to the native annular anatomy, as well as the implantation depth of the index and second bioprostheses. Placement of an S3 at a lower Evolut position may reduce the risk of coronary flow compromise while preserving coronary access.

Original languageEnglish
Pages (from-to)E330-E339
JournalEuroIntervention
Volume19
Issue number4
DOIs
StatePublished - Jul 2023

Keywords

  • TAVI
  • aortic stenosis
  • valve-in-valve

Fingerprint

Dive into the research topics of 'Feasibility of redo-TAVI in self-expanding Evolut valves: a CT analysis from the Evolut Low Risk Trial substudy'. Together they form a unique fingerprint.

Cite this